ODTCD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ODTCD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Odonate's sale of investment for the three months ended in Sep. 2021 was $0.00 Mil. It means Odonate gained $0.00 Mil from selling investments. Odonate's sale of investment for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00 Mil.
Compared with last quarter ($0.00 Mil in Jun. 2021 ), Odonate gained the same money from selling investments in Sep. 2021 ($0.00 Mil).
The historical data trend for Odonate's Sale Of Investment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Odonate Annual Data | |||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | |||||||||
Sale Of Investment | Get a 7-Day Free Trial | - | - | - | - | - |
Odonate Quarterly Data | ||||||||||||||||||||
Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | |
Sale Of Investment | Get a 7-Day Free Trial | - | - | - | - | - |
Sale of Investments represents cash inflow on the sale of investments in securities.
Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Odonate's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.
Ecor1 Capital, Llc | 10 percent owner | 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103 |
Boxer Capital, Llc | director, 10 percent owner | 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130 |
Kevin C Tang | director, 10 percent owner, officer: Chief Executive Officer | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
Aaron I. Davis | director, 10 percent owner | 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130 |
Craig A Johnson | director | C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Jeff L Vacirca | director | 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121 |
Laura L. Johnson | director | C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122 |
Michael S Hearne | officer: Chief Financial Officer | 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 |
Joseph P O'connell | officer: Chief Medical Officer | 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 |
Boxer Asset Management Inc. | 10 percent owner | CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000 |
Robert Rosen | director | C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121 |
Joseph Lewis | 10 percent owner | PO BOX N7776, LYFORD BAHAMAS |
Tang Capital Management Llc | 10 percent owner | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
Tang Capital Partners Lp | 10 percent owner | 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121 |
John G Lemkey | officer: Chief Financial Officer | 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 11-20-2021
By GuruFocus Research GuruFocus Editor • 12-23-2020
By Business Wire Business Wire • 11-16-2020
By Marketwired Marketwired • 11-12-2020
By Business Wire Business Wire • 12-11-2020
By Marketwired Marketwired • 11-03-2020
By GuruFocusNews GuruFocusNews • 02-07-2022
By Marketwired Marketwired • 11-05-2020
By PRNewswire PRNewswire • 11-01-2020
By Marketwired Marketwired • 11-15-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.